PMV Pharmaceuticals (PMVP)
(Delayed Data from NSDQ)
$1.52 USD
+0.04 (2.70%)
Updated Aug 6, 2025 04:00 PM ET
After-Market: $1.51 -0.01 (-0.66%) 7:56 PM ET
3-Hold of 5 3
D Value F Growth F Momentum F VGM
Fundamental Charts
About Market Cap
As of the previous market close, PMV Pharmaceuticals, Inc. has a market cap of $76.89M, which represents its share price of $1.48 multiplied by its outstanding shares number of 51.95M. As a small-cap company, PMVP's shareholders are generally exposed to more risk than shareholders of mid and large-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
PMVP 1.52 +0.04(2.70%)
Will PMVP be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for PMVP based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for PMVP
Here's Why PMV Pharmaceuticals (PMVP) Looks Ripe for Bottom Fishing
PMVP: What are Zacks experts saying now?
Zacks Private Portfolio Services
Other News for PMVP
PMV Pharmaceuticals Holds 2025 Annual Stockholder Meeting
PMV Pharmaceuticals to Participate at Upcoming Investor Conferences | PMVP Stock News
TD Cowen Keeps Their Buy Rating on PMV Pharmaceuticals (PMVP)
PMV Pharmaceuticals Reports Q1 2025 Financial Results
PMV Pharmaceuticals GAAP EPS of -$0.34 beats by $0.03